201 related articles for article (PubMed ID: 23964079)
1. The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly.
Escudero-Esparza A; Kalchishkova N; Kurbasic E; Jiang WG; Blom AM
FASEB J; 2013 Dec; 27(12):5083-93. PubMed ID: 23964079
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
3. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
Barilla-LaBarca ML; Liszewski MK; Lambris JD; Hourcade D; Atkinson JP
J Immunol; 2002 Jun; 168(12):6298-304. PubMed ID: 12055245
[TBL] [Abstract][Full Text] [Related]
4. Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase.
Holmquist E; Okroj M; Nodin B; Jirström K; Blom AM
FASEB J; 2013 Jun; 27(6):2355-66. PubMed ID: 23482636
[TBL] [Abstract][Full Text] [Related]
5. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
Iwata K; Seya T; Yanagi Y; Pesando JM; Johnson PM; Okabe M; Ueda S; Ariga H; Nagasawa S
J Biol Chem; 1995 Jun; 270(25):15148-52. PubMed ID: 7541036
[TBL] [Abstract][Full Text] [Related]
6. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.
Fukui A; Yuasa-Nakagawa T; Murakami Y; Funami K; Kishi N; Matsuda T; Fujita T; Seya T; Nagasawa S
J Biochem; 2002 Nov; 132(5):719-28. PubMed ID: 12417021
[TBL] [Abstract][Full Text] [Related]
7. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
Blom AM; Kask L; Dahlbäck B
Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
[TBL] [Abstract][Full Text] [Related]
8. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
9. Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors.
Okroj M; Hsu YF; Ajona D; Pio R; Blom AM
Mol Immunol; 2008 Jan; 45(1):169-79. PubMed ID: 17548110
[TBL] [Abstract][Full Text] [Related]
10. NC4 Domain of cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H.
Kalchishkova N; Fürst CM; Heinegård D; Blom AM
J Biol Chem; 2011 Aug; 286(32):27915-26. PubMed ID: 21659506
[TBL] [Abstract][Full Text] [Related]
11. Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function.
Liszewski MK; Leung MK; Atkinson JP
J Immunol; 1998 Oct; 161(7):3711-8. PubMed ID: 9759896
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of negative complement regulators by the saprophyte Leptospira biflexa expressing LigA or LigB confers enhanced survival in human serum.
Castiblanco-Valencia MM; Fraga TR; Breda LC; Vasconcellos SA; Figueira CP; Picardeau M; Wunder E; Ko AI; Barbosa AS; Isaac L
Immunol Lett; 2016 May; 173():61-8. PubMed ID: 26976804
[TBL] [Abstract][Full Text] [Related]
13. Leptospira interrogans Lsa23 protein recruits plasminogen, factor H and C4BP from normal human serum and mediates C3b and C4b degradation.
Siqueira GH; Atzingen MV; de Souza GO; Vasconcellos SA; Nascimento ALTO
Microbiology (Reading); 2016 Feb; 162(2):295-308. PubMed ID: 26614523
[TBL] [Abstract][Full Text] [Related]
14. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
Duvall MR; Hwang HY; Boackle RJ
Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
[TBL] [Abstract][Full Text] [Related]
16. Functions of human complement inhibitor C4b-binding protein in relation to its structure.
Blom AM; Villoutreix BO; Dahlbäck B
Arch Immunol Ther Exp (Warsz); 2004; 52(2):83-95. PubMed ID: 15179322
[TBL] [Abstract][Full Text] [Related]
17. The surface protease PgtE of Salmonella enterica affects complement activity by proteolytically cleaving C3b, C4b and C5.
Ramu P; Tanskanen R; Holmberg M; Lähteenmäki K; Korhonen TK; Meri S
FEBS Lett; 2007 May; 581(9):1716-20. PubMed ID: 17418141
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.
Avirutnan P; Fuchs A; Hauhart RE; Somnuke P; Youn S; Diamond MS; Atkinson JP
J Exp Med; 2010 Apr; 207(4):793-806. PubMed ID: 20308361
[TBL] [Abstract][Full Text] [Related]
19. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
20. Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I.
Nilsson SC; Kalchishkova N; Trouw LA; Fremeaux-Bacchi V; Villoutreix BO; Blom AM
Eur J Immunol; 2010 Jan; 40(1):172-85. PubMed ID: 19877009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
